Abano Healthcare Group Limited reported consolidated financial results for the year ended May 31, 2017. For the year, revenue was NZD 233.532 million against NZD 213.744 million for the same period of last year. Operating profit was NZD 21.155 million compared to NZD 16.858 million a year ago. Profit before income tax was NZD 16.084 million compared to NZD 31.821 million a year ago. Profit attributable to equity holders of the company share of profit was NZD 10.879 million compared to NZD 28.442 million a year ago. Net cash generated from operating activities was NZD 22.452 million was NZD 20.045 million for the same period of last year. Purchase of property, plant and equipment was NZD 11.254 million against NZD 13.831 million for the same period of last year. Underlying EBITDA was NZD 32.1 million against NZD 27.2 million for the same period of last year. EBITDA was NZD 31.4 million against NZD 26.6 million for the same period of last year. Underlying NPAT was NZD 11.5 million compared to NZD 8.8 million a year ago. Net assets per security were NZD 5.52 compared to NZD 5.41 a year ago. Underlying earnings per share were 53.8 cents per share, an increase of 29% and exceeding company's growth objective of greater than 15% per annum.